These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 4679652

  • 1. Clinical observations on the use of primozide in the treatment of chronic schizophrenics.
    Frangos E.
    Acta Psychiatr Belg; 1972 Nov; 72(6):698-707. PubMed ID: 4679652
    [No Abstract] [Full Text] [Related]

  • 2. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
    Gross HS.
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
    [No Abstract] [Full Text] [Related]

  • 3. Pimozide as an adjuvant to maintenance therapy in chronic schizophrenia.
    Nakra BR, Wickramasinghe NA.
    Pharmatherapeutica; 1980 Jul; 2(5):337-40. PubMed ID: 6107933
    [Abstract] [Full Text] [Related]

  • 4. Clinical trial of pimozide.
    Anumonye A, Onibuwe-Johnson T, Marinho AA.
    West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):17-24. PubMed ID: 799401
    [Abstract] [Full Text] [Related]

  • 5. Pimozide and the social behavior of schizophrenics.
    Lapierre YD, Lavallee J.
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
    [No Abstract] [Full Text] [Related]

  • 6. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y.
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pimozide in the treatment of some "social maladjustments" in "personality disorders".
    Collard J.
    Acta Psychiatr Belg; 1979 Nov; 79(6):686-703. PubMed ID: 554447
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL, Vereecken JL.
    Psychiatr Neurol Neurochir; 1973 Nov; 76(1):47-59. PubMed ID: 4699105
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Results obtained with Orap in the therapy of neuropsychiatric outpatients.
    Perényi G, Várkonyi B+VARKONYI B.
    Ther Hung; 1974 Nov; 22(2):65-8. PubMed ID: 4608508
    [No Abstract] [Full Text] [Related]

  • 18. Two pilot studies of AHR-1680 in chronic schizophrenic patients.
    Sugerman AA, Herrmann J, O'Hara M, Simpson GM, Angus JW, Deutsch L.
    J Clin Pharmacol J New Drugs; 1969 Nov; 9(3):183-6. PubMed ID: 4892454
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Evaluation of the hypnotic properties of promethazine in chronic schizophrenics].
    Massac CH, Pinard G, Côte JY, Tétreault L.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):251-9. PubMed ID: 5550422
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.